National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 617744

History of Changes from the VAERS Wayback Machine

First Appeared on 3/14/2016

VAERS ID: 617744
VAERS Form:
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / - LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


Changed on 9/14/2017

VAERS ID: 617744 Before After
VAERS Form:(blank) 1
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / - UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / - UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


Changed on 2/14/2018

VAERS ID: 617744 Before After
VAERS Form:1
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


Changed on 6/14/2018

VAERS ID: 617744 Before After
VAERS Form:1
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


Changed on 8/14/2018

VAERS ID: 617744 Before After
VAERS Form:1
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


Changed on 9/14/2018

VAERS ID: 617744 Before After
VAERS Form:1
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


Changed on 10/14/2018

VAERS ID: 617744 Before After
VAERS Form:1
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


Changed on 12/24/2020

VAERS ID: 617744 Before After
VAERS Form:1
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


Changed on 12/30/2020

VAERS ID: 617744 Before After
VAERS Form:1
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


Changed on 5/7/2021

VAERS ID: 617744 Before After
VAERS Form:1
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


Changed on 5/14/2021

VAERS ID: 617744 Before After
VAERS Form:1
Age:16.0
Sex:Female
Location:Unknown
Vaccinated:2015-11-06
Onset:2015-11-06
Submitted:2016-01-05
Entered:2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK LA / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Malaise, Pyrexia, Tenderness, Injection site swelling

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=617744&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166